AAAAAA
Results:
1-12
|
Results: 12
Authors:
El Mir, S
Casanova, A
Betbeder, D
Triebel, F
Citation: S. El Mir et al., A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration, EUR J CANC, 37(8), 2001, pp. 1053-1060
Authors:
Demeure, CE
Wolfers, J
Martin-Garcia, N
Gaulard, P
Triebel, F
Citation: Ce. Demeure et al., T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts, EUR J CANC, 37(13), 2001, pp. 1709-1718
Authors:
Huard, B
Karlsson, L
Triebel, F
Citation: B. Huard et al., KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation, EUR J IMMUN, 31(6), 2001, pp. 1728-1735
Authors:
Iouzalen, N
Andreae, S
Hannier, S
Triebel, F
Citation: N. Iouzalen et al., LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway, EUR J IMMUN, 31(10), 2001, pp. 2885-2891
Authors:
Merad, M
Angevin, E
Wolfers, T
Flament, C
Lorenzi, I
Triebel, F
Escudier, B
Zitvogel, L
Citation: M. Merad et al., Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12), J IMMUNOTH, 23(3), 2000, pp. 369-378
Authors:
El Mir, S
Triebel, F
Citation: S. El Mir et F. Triebel, A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvantelicits greater humoral and cellular immune responses to both particulate and soluble antigens, J IMMUNOL, 164(11), 2000, pp. 5583-5589
Authors:
Hannier, S
Triebel, F
Citation: S. Hannier et F. Triebel, The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes, INT IMMUNOL, 11(11), 1999, pp. 1745-1752
Authors:
Angevin, E
Glukhova, L
Pavon, C
Chassevent, A
Terrier-Lacombe, MJ
Goguel, AF
Bougaran, J
Ardouin, P
Court, BH
Perrin, JL
Vallancien, G
Triebel, F
Escudier, B
Citation: E. Angevin et al., Human renal cell carcinoma xenografts in SCID mice: Tumorigenicity correlates with a poor clinical prognosis, LAB INV, 79(7), 1999, pp. 879-888
Authors:
Ronsin, C
Chung-Scott, V
Poullion, I
Aknouche, N
Gaudin, C
Triebel, F
Citation: C. Ronsin et al., A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ, J IMMUNOL, 163(1), 1999, pp. 483-490
Authors:
Avice, MN
Sarfati, M
Triebel, F
Delespesse, G
Demeure, CE
Citation: Mn. Avice et al., Lymphocyte activation gene-3, a MHC class II ligand expressed on activatedT cells, stimulates TNF-alpha and IL-alpha production by monocytes and dendritic cells, J IMMUNOL, 162(5), 1999, pp. 2748-2753
Authors:
Gaudin, C
Kremer, R
Angevin, E
Scott, V
Triebel, F
Citation: C. Gaudin et al., A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma, J IMMUNOL, 162(3), 1999, pp. 1730-1738
Authors:
Prigent, P
El mir, S
Dreano, M
Triebel, F
Citation: P. Prigent et al., Lymphocyte activation gene-3 induces tumor regression and antitumor immuneresponses, EUR J IMMUN, 29(12), 1999, pp. 3867-3876
Risultati:
1-12
|